- Home
- KYIV vs VKTX Comparison
KYIV vs VKTX Comparison
Compare KYIV & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KYIV | VKTX |
|---|---|---|
| Founded | 1994 | 2012 |
| Country | United Arab Emirates | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 3.5B |
| IPO Year | 2025 | 2014 |
Fundamental Metrics
Financial Performance| Metric | KYIV | VKTX |
|---|---|---|
| Price | $12.88 | $28.92 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 21 |
| Target Price | $18.87 | ★ $95.32 |
| AVG Volume (30 Days) | 590.4K | ★ 4.3M |
| Earning Date | 11-06-2026 | 10-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $16.85 | N/A |
| Revenue Next Year | $7.95 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.29 | $23.82 |
| 52 Week High | $16.55 | $43.15 |
Technical Indicators
Market Signals| Indicator | KYIV | VKTX |
|---|---|---|
| Relative Strength Index (RSI) | 47.85 | 53.60 |
| Support Level | $11.25 | $27.66 |
| Resistance Level | $14.14 | $34.00 |
| Average True Range (ATR) | 0.49 | 1.69 |
| MACD | -0.01 | 0.56 |
| Stochastic Oscillator | 17.29 | 78.03 |
Price Performance
Historical ComparisonAbout KYIV Kyivstar Group Ltd.
Kyivstar Group Ltd is a telecommunications and digital holding company that operates Ukraine provider of mobile communication and broadband services. The company offers a wide range of connectivity and digital services, including mobile and fixed-line voice and data, ride-hailing, e-health, digital TV, and enterprise solutions such as big data, cloud, and cybersecurity. It operates through two main segments: Telecommunications and Digital. The Telecommunications segment, which generates the majority of revenue, includes service revenue from mobile and fixed connectivity services provided to both individual and corporate customers. The Digital segment comprises revenue from proprietary digital platforms and services.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.